MedTrace Logo

Comparison Between Intraligamentary Piroxicam and Articaine

NCT03612323 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-08-02

No results posted yet for this study

Summary

Comparing the efficacy of intra-ligamentary Piroxicam and intra-ligamentary Articaine on pain during and after endodontic treatment of mandibular molars with symptomatic irreversible pulpitis.

Conditions

  • Pulpitis - Irreversible

Interventions

DRUG

Intra-ligamentary Piroxicam

Piroxicam is a long-acting potent analgesic non selective oxicams derivative, has a half-life of 50 hrs in the plasma.The onset of action of oral piroxicam is 2-4 hrs, but it is anticipated that injectable piroxicam could produce more rapid onset of action. It could favourably overcome the intense pain up to 48 hrs following the treatment

DRUG

Intra-ligamentary Articaine

Articaine is a local anesthetic agent , has been reported to be an effective anesthetic in controlling pain during root canal treatment

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Lobna Elhadad, Student · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-30
Primary Completion
2019-05-31
Completion
2019-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03612323 on ClinicalTrials.gov